dipyridamole has been researched along with Schwartzman Phenomenon in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dipyridamole treatment of rabbits caused significant inhibition of fibrin deposition in all three experimental models." | 1.25 | Inhibition of intravascular fibrin deposition by dipyridamole in experimental animals. ( Gurewich, V; Lipinski, B; Wetmore, R, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gurewich, V | 1 |
| Lipinski, B | 1 |
| Wetmore, R | 1 |
| Ekert, E | 1 |
2 other studies available for dipyridamole and Schwartzman Phenomenon
| Article | Year |
|---|---|
Inhibition of intravascular fibrin deposition by dipyridamole in experimental animals.
Topics: Aminocaproates; Animals; Autoradiography; Blood Platelets; Dipyridamole; Disease Models, Animal; End | 1975 |
Letter: Thrombolytic therapy in haemolytic-uraemic syndrome.
Topics: Child; Dipyridamole; Hemolytic-Uremic Syndrome; Heparin; Humans; Shwartzman Phenomenon; Streptokinas | 1974 |